The Basic Principles Of Piceatannol 4'-O-?-D-glucopyranoside
All enrolled patients who obtained a minimum of one particular dose of zosuquidar or placebo in the course of induction ended up monitored for the prevalence of adverse activities (439 clients, 219 on zosuquidar and 210 on placebo). The commonest adverse events had been connected with the period of prolonged and important myelosuppression as is pre